Variable clinical expression of a novel FLNC truncating variant in a large family
- PMID: 38360096
- DOI: 10.1016/j.ijcard.2024.131849
Variable clinical expression of a novel FLNC truncating variant in a large family
Abstract
Background: Variants in Filamin-C (FLNC) have been associated with various hereditary cardiomyopathies. Recent literature reports a prevalence of sudden cardiac death (SCD) of 13-25% among carriers of truncating-variants, with mean age of 42±15 years for first SCD event. This study reports two familial cases of SCD and the results of cascade screening of their large family.
Methods: Molecular-autopsy of the SCD victims revealed a novel truncating-variant in the FLNC gene (chr 7:128496880 [hg19]; NM_001458.5; c.7467_7474del; p.(Ser2490fs)). We screened thirty-two family members following genetic counseling, and variant carriers underwent a comprehensive workup followed by consultation with a cardiologist with expertise in the genetics of cardiac diseases.
Results: Seventeen variant carriers were identified: ages between 9 and 85 (mean 47±26). Fifteen underwent clinical evaluation. To date, none of the identified carriers has had major adverse events. In evaluated patients, ECG showed right-axis deviation in 60% (n = 9). Holter recorded frequent premature ventricular contractions (PVCs) (991±2030 per 24 h) in 33% (n = 5) with 4 patients having polymorphic PVC morphology. Three carriers had echocardiographic evidence of mild left-ventricular (LV) systolic dysfunction and another with mild LV dilatation. Cardiac magnetic-resonance (CMR) exhibited late‑gadolinium-enhancement in 10 out of 11 exams, mainly in the mid-myocardium and sub-epicardium, frequently involving the septum and the inferior-lateral wall.
Conclusion: This large FLNC truncating variant carrier family exhibits high cardiomyopathy penetrance, best diagnosed by CMR, with variable clinical expressions. These findings present a challenge in SCD prevention management and underscoring the imperative for better risk stratification measures.
Keywords: Arrhythmogenic cardiomyopathy; FLNC; Filamin-C; Sudden cardiac death; Truncating variant.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have no conflicts to disclose.
Similar articles
-
Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death.Heart Rhythm. 2022 Feb;19(2):235-243. doi: 10.1016/j.hrthm.2021.09.029. Epub 2021 Oct 1. Heart Rhythm. 2022. PMID: 34601126
-
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.J Am Coll Cardiol. 2016 Dec 6;68(22):2440-2451. doi: 10.1016/j.jacc.2016.09.927. J Am Coll Cardiol. 2016. PMID: 27908349
-
Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype.Int J Cardiol. 2020 May 15;307:101-108. doi: 10.1016/j.ijcard.2019.09.048. Epub 2019 Oct 8. Int J Cardiol. 2020. PMID: 31627847
-
Filamin C in cardiomyopathy: from physiological roles to DNA variants.Heart Fail Rev. 2022 Jul;27(4):1373-1385. doi: 10.1007/s10741-021-10172-z. Epub 2021 Sep 17. Heart Fail Rev. 2022. PMID: 34535832 Review.
-
A mutation update for the FLNC gene in myopathies and cardiomyopathies.Hum Mutat. 2020 Jun;41(6):1091-1111. doi: 10.1002/humu.24004. Epub 2020 Mar 20. Hum Mutat. 2020. PMID: 32112656 Free PMC article. Review.
Cited by
-
Novel FLNC variants in pediatric cardiomyopathy: an insight into disease mechanisms.Hum Genomics. 2024 Oct 29;18(1):118. doi: 10.1186/s40246-024-00683-9. Hum Genomics. 2024. PMID: 39472949 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical